Clinical Research Education for Drug Abuse Professionals
Clinical Research Education for Drug Abuse Professionals
批准号:
8231271
负责人:
Thomas Frederick Newton
金额:
$24.73万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-03-01 至 2016-02-29
关键词:
AccountabilityAddressApplications GrantsAreaBehavior TherapyBrain imagingClinicalClinical ResearchClinical TrialsCollaborationsCommunitiesCompetenceDrug AddictionDrug abuseEducationEducational CurriculumEducational process of instructingEnsureEnvironmentEthnic groupEvaluationFacultyFundingGoalsGrantHealth ProfessionalHealth Services ResearchHome environmentHospitalsHumanImmersion Investigative TechniqueInstitutionInvestigationJournalsKnowledgeManuscriptsMedical centerMedicineMentorsMethodsNational Institute of Drug AbusePeer ReviewPharmaceutical PreparationsPharmacologyPharmacotherapyPhysiciansPopulationPostdoctoral FellowPsychiatristPublicationsReportingResearchResearch InfrastructureResearch MethodologyResearch PersonnelResearch TrainingResidenciesSiteTechniquesTechnologyTestingTexasTrainingTraining ProgramsTraining and EducationUnited States National Institutes of HealthUniversitiesValidity and ReliabilityWomanWritingaddictionbaseclinical practicecognitive neurosciencecollegedrug abuse educationexperienceforgingimprovedinnovationmedical schoolsmeetingsneurochemistryneurogeneticspre-clinicalprogramspublic health relevanceracial and ethnicresponsesymposium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This new application is submitted to initiate a Clinical Research Education for Drug Abuse Professionals (CREDAP) training program at Baylor College of Medicine, based on the successful CREDAP that was previously sited at UCLA. The overarching goal is to provide a coordinated, sustainable infrastructure of dedicated education and training that will produce independent healthcare professionals capable of conducting and disseminating clinical research pertaining to drug dependence and its treatment. This extensively revised application features an expansion of available mentors and research opportunities to include Pre-Clinical Human Pharmacology and Medications Testing (Drs. Newton, De La Garza), Brain Imaging and Cognitive Neuroscience (Drs. Moeller, Lane, and Steinberg), Neurogenetics (Dr. Nielson), Neurochemical Correlates of Addiction (Dr. Little) and Clinical Trials Research (Dr. Kosten). In addition, the program includes more extensive mechanisms of ensuring accountability of both faculty and trainees with the goal of consistently producing trainees that are able to successfully compete for funding. The specific aims of the program are: 1. to provide trainees with a comprehensive understanding of drug abuse research and clinical practice, entailing interdisciplinary clinical research education and training lasting two years at post-doctoral level under the guidance of preceptors. 2. To educate trainees to have full competence in using experimental techniques appropriate for the investigation of drug abuse, emphasizing advanced technologies, procedural reliability, and validity. 3. To encourage trainees to investigate a defined clinical research issue in drug abuse, with a focus on clinical trials research, starting them on a course of clinical research that will continue beyond the 2-year program. 4. To prepare trainees to become productive clinical researchers by teaching them to prepare manuscripts reporting research results that merit publication in peer-reviewed, high-quality biomedical journals, to write and submit grant applications to the NIH, and to become part of national research communities by attending meetings, seminars, and symposia where they may present research, gain new knowledge, and forge new collaborations. 5. To increase diversity in the training program through identifying and soliciting applications from promising candidates from underrepresented populations, including racial/ethnic groups and women. 6. To further develop and refine the program through formal evaluation efforts that provide input on areas that can be improved.
PUBLIC HEALTH RELEVANCE: This revised application is submitted for continuation of the Clinical Research Education for Drug Abuse Professionals (CREDAP) training program. The overarching goal is to provide a coordinated, sustainable infrastructure of dedicated education and training that will produce independent healthcare professionals capable of conducting and disseminating clinical research pertaining to drug dependence and its treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Triple Re-uptake Inhibitor, SKL 10406, as a New Treatment for Alcohol Dependence
-
批准号:8834162
-
项目类别:
-
资助金额:$13.99万
-
财政年份:2015
-
负责人:Thomas Frederick Newton
-
依托单位:
Carisbamate Treatment for Alcohol Dependence
-
批准号:8735477
-
项目类别:
-
资助金额:$75.23万
-
财政年份:2013
-
负责人:Thomas Frederick Newton
-
依托单位:
Carisbamate Treatment for Alcohol Dependence
-
批准号:8455440
-
项目类别:
-
资助金额:$10.69万
-
财政年份:2013
-
负责人:Thomas Frederick Newton
-
依托单位:
Carisbamate Treatment for Alcohol Dependence
-
批准号:8900485
-
项目类别:
-
资助金额:$13.93万
-
财政年份:2013
-
负责人:Thomas Frederick Newton
-
依托单位:
Clinical Research Education for Drug Abuse Professionals
-
批准号:8433405
-
项目类别:
-
资助金额:$22.25万
-
财政年份:2011
-
负责人:Thomas Frederick Newton
-
依托单位:
Clinical Research Education for Drug Abuse Professionals
-
批准号:8624682
-
项目类别:
-
资助金额:$24.71万
-
财政年份:2011
-
负责人:Thomas Frederick Newton
-
依托单位:
Clinical Research Education for Drug Abuse Professionals
-
批准号:7861881
-
项目类别:
-
资助金额:$25.3万
-
财政年份:2011
-
负责人:Thomas Frederick Newton
-
依托单位:
N-ACETYLCYSTEINE AS A POTENTIAL TREATMENT FOR METHAMPHETAMINE DEPENDENCE
-
批准号:8356780
-
项目类别:
-
资助金额:$0.59万
-
财政年份:2010
-
负责人:Thomas Frederick Newton
-
依托单位:
THE EFFECTS OF DOXAZOSIN ON THE CARDIOVASCULAR AND SUBJECTIVE EFFECTS OF COCAINE
-
批准号:8356781
-
项目类别:
-
资助金额:$1.07万
-
财政年份:2010
-
负责人:Thomas Frederick Newton
-
依托单位:
AN ACE INHIBITOR AS A TREATMENT FOR METHAMPHETAMINE DEPENDENCE
-
批准号:8356772
-
项目类别:
-
资助金额:$4.39万
-
财政年份:2010
-
负责人:Thomas Frederick Newton
-
依托单位:
N-acetylcysteine as a Potential Treatment for Methamphetamine Dependence
-
批准号:7647519
-
项目类别:
-
资助金额:$22.99万
-
财政年份:2009
-
负责人:Thomas Frederick Newton
-
依托单位:
AN ACE INHIBITOR AS A TREATMENT FOR METHAMPHETAMINE DEPENDENCE
-
批准号:8166769
-
项目类别:
-
资助金额:$3.4万
-
财政年份:2009
-
负责人:Thomas Frederick Newton
-
依托单位:
LABORATORY MODELS OF COCAINE SELF ADMINISTRATION
-
批准号:8166772
-
项目类别:
-
资助金额:$2.67万
-
财政年份:2009
-
负责人:Thomas Frederick Newton
-
依托单位:
An ACE Inhibitor as a Treatment for Methamphetamine Dependence
-
批准号:8075637
-
项目类别:
-
资助金额:$36.85万
-
财政年份:2008
-
负责人:Thomas Frederick Newton
-
依托单位:
An ACE Inhibitor as a Treatment for Methamphetamine Dependence
-
批准号:7467168
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2008
-
负责人:Thomas Frederick Newton
-
依托单位:
INHIBITORY CONTROL AND MA SELF-ADMINISTRATION MODAFINIL EFFECTS
-
批准号:7689048
-
项目类别:
-
资助金额:$11.79万
-
财政年份:2008
-
负责人:Thomas Frederick Newton
-
依托单位:
An ACE Inhibitor as a Treatment for Methamphetamine Dependence
-
批准号:7842579
-
项目类别:
-
资助金额:$37.99万
-
财政年份:2008
-
负责人:Thomas Frederick Newton
-
依托单位:
An ACE Inhibitor as a Treatment for Methamphetamine Dependence
-
批准号:7664340
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2008
-
负责人:Thomas Frederick Newton
-
依托单位:
An ACE Inhibitor as a Treatment for Methamphetamine Dependence
-
批准号:8266332
-
项目类别:
-
资助金额:$36.85万
-
财政年份:2008
-
负责人:Thomas Frederick Newton
-
依托单位:
NIDA-1 P50 DA 018185: DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF R
-
批准号:7606798
-
项目类别:
-
资助金额:$19.54万
-
财政年份:2007
-
负责人:Thomas Frederick Newton
-
依托单位:
海外基金